Antibody-mediated allograft rejection is associated with an increase in peripheral differentiated CD28-CD8+ T cells – Analyses of a cohort of 1032 kidney transplant recipients

• Published in: EBioMedicine 2022-09, Vol.83, p.104226-104226, Article 104226
• Main Authors: Mai, Hoa Le, Degauque, Nicolas, Le Bot, Sabine, Rimbert, Marie, Renaudin, Karine, Danger, Richard, Le Borgne, Florent, Kerleau, Clarisse, Tilly, Gaelle, Vivet, Anaïs, Delbos, Florent, Walencik, Alexandre, Giral, Magali, Brouard, Sophie
• Format: Article
• Language: English
• Subjects: Antibody; CD28; CD8; Kidney transplantation; Life Sciences; Rejection; T lymphocyte
• ISSN: 2352-3964; 2352-3964
• DOI: 10.1016/j.ebiom.2022.104226

CD28-CD8+ T cells represent a differentiated CD8+ T cell subset that is found to be increased in various conditions associated with chronic antigenic stimulation such as aging, chronic viral infections, autoimmune diseases, cancers, and allotransplantation. Using multivariate models, we analyzed a large cohort of 1032 kidney transplant patients in whom 1495 kidney graft biopsies were performed concomitant with a peripheral blood leukocyte phenotyping by flow cytometry. We investigated the association between the level of CD28-CD8+ T cells in the blood and the diagnosis of graft rejection according to the recent Banff classification of renal allograft pathology. We found that antibody-mediated rejection (ABMR) was associated with a significant increase in the percentage as well as the absolute number of CD28-CD8+ T cells in the peripheral blood of kidney transplant patients at the time of biopsy. The confounder-adjusted mean difference of log percentage and log absolute value between the ABMR group and the normal/subnormal histology group were 0.29 (p=0.0004) and 0.38 (p=0.0004), respectively. Moreover, we showed that CD28-CD8+ T cells from the patients diagnosed with ABMR responded more rigorously to TCR and FcγRIIIA (CD16) engagement compared to their CD28+ counterparts as evidenced by an increase in the expression of IFNγ, TNFα, and CD107a. Collectively, our data suggest that differentiated CD28-CD8+ T cells, with increased frequency, number, and function, may participate in the pathobiology of ABMR. Further studies are warranted to clarify the immunological role of this T cell subset in kidney graft rejection. Agence nationale de la recherche (France).